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We report a case of punctate inner choroidopathy (PIC) treated with oral prednisolone and intravitreous
bevacizumab injection (IVB). The case was studied and followed for 5 months by serial spectrum-domain
optical coherence tomography (SD-OCT). At the early active phase of PIC, SD-OCT showed dome-shaped
retinal pigment epithelium (RPE) elevation with underlying intact Bruch’s membrane (BM), overlying
photoreceptor inner/outer segment junction (PRJ) disappearance, and homogenous hyperreﬂective sub-
RPE signals. After oral prednisolone and IVB, SD-OCT showed resolution of RPE changes with overlying
intact PRJ. Further, the localized outer retinal layers were found to gradually move outward. Our case of
PIC was followed by SD-OCT and was successfully treated with oral prednisolone and IVB. SD-OCT may
play an important role in early identiﬁcation of PIC and evaluation of disease progression. According to
the serial changes in SD-OCT, we hypothesize that the origin of PIC is most likely to be localized at the
RPE level. Early detection and intervention may prevent the progression of PIC to choroidal neo-
vascularization and may lead to good prognosis.
Copyright  2013, The Ophthalmologic Society of Taiwan. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Punctate inner choroidopathy (PIC) is a rare idiopathic ocular
inﬂammatory disease. It was ﬁrst reported by Watzke et al in 1984
to describe the multifocal, yellow-white, well-circumscribed
choroidal lesions over the posterior pole in 10 myopic female pa-
tients.1 These lesions may evolve variably into hyperpigmented
scars, with atrophic changes at the level of the inner choroid and
retinal pigment epithelium (RPE), or subretinal choroidal neo-
vascularization (CNV).2 There is no sign of inﬂammation elsewhere
in the eyes. Image studies have revealed ﬂuorescent dye leakage of
the active lesions on ﬂuorescein angiography (FA)3e6 and involve-
ment of choriocapillaries on indocyanine green angiography
(ICG).3,7,8 However, to date, the exact localization of the origin of PIC
lesions remains unclear.
With advances in the technique of optical coherence to-
mography (OCT), it is increasingly being used in studies for aave no conﬂicts of interest.
logy, Taipei Veterans General
iwan.
).
e Ophthalmologic Society of Taiwdetailed morphological view of the retina, even of the choroid. In
2012, Channa et al9 reported characteristic ﬁndings by SD-OCT in
a retrospective, observational case series with PIC lesions. They
had collected 27 lesions from seven patients (8 eyes), and clas-
siﬁed them into four categories according to the disease activity
and temporal changes. The lesions with CNV were excluded.
They concluded that early active lesions were characterized by
RPE elevation and photoreceptor inner/outer segment junction
(PRJ) disruption. However, there was no detailed description in
treatment and serial follow-up by SD-OCT.
In this report, we aimed to utilize the high resolution SD-OCT
with its enhanced depth imaging (EDI) mode to follow up a case
with active PIC lesions treated with oral prednisolone and intra-
vitreous bevacizumab (Avastin, Genetech, San Francisco, CA, USA)
injection (IVB), and to hypothesize the original localization in this
rare disease.2. Case report
A 32-year-old Asian female with myopia initially complained of
white patches of the central scotoma in her left eye from January 8,an. Published by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. (A-1 and A-2) At the ﬁrst visit, the color photograph demonstrated multiple yellow-white lesions over the posterior pole in the left eye, and the three active punctate inner
choroidopathy (PIC) lesions were at the fovea, causing the central scotoma (white arrowheads). (B-1 and B-2) FA revealed hyperﬂuorescent PIC lesions with gradual staining and
mild leakage in the late phase. (C-1 and C-2) indocyanine green angiography (ICG) showed hypoﬂuorescent PIC lesions; only one bigger active lesion temporal-superior to the fovea
showed a hyperﬂuorescent crescent area at the margin (yellow arrow), which may represent choroidal vasculitis or oncoming neovascularization.
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any systemic disease, ocular disease, or family history. She
mentioned travel history to Thailand on January 4, 2013, and oc-
casional contact history with cats; she denied any contact history
with soil, bats, or birds. The serum laboratory data was normal for
complete blood count and biochemistry. Enzyme immunoassays of
herpes simplex virus and herpes zoster virus were also arranged, to
rule out virus infection; the reports were all negative.
On ophthalmic examination, the best corrected visual acuity
showed 6/6 in both eyes. The spherical equivalent refraction was
approximately 7 diopters in both eyes. There were no inﬂam-
matory signs in the anterior chamber or vitreous humor. Fundo-
scopy revealed multiple yellow-white lesions over the posterior
pole and some old punch-out lesions near the arcades (Fig. 1A). No
peripheral lesion was present. FA of these yellow-white lesionsrevealed hyperﬂuorescence in the mid-phase with gradual staining
and mild leakage in the late phase (Fig. 1B). ICG showed the
following: multiple hypoﬂuorescent spots in the early, middle, and
late phases; the small hyperﬂuorescent crescent area at the margin
of one hypoﬂuorescent spot (Fig. 1C), which was temporal-superior
to the fovea, may represent choroidal vasculitis7 or oncoming
neovascularization.
Cirrus SD-OCT (CirrusHD-OCT, Carl ZeissMeditec,Dublin, CA,USA)
in high deﬁnition raster with EDI mode (software: version 6.0) was
performed at the ﬁrst visit and revealed (Fig. 2A): (1) dome-shaped
RPE elevation with underlying intact Bruch’s membrane (BM); (2)
overlying disappearance of the photoreceptor junction (PRJ); (3)
localized homogenous hyperreﬂective signals below the RPE.
On Day 1, we started to administer oral prednisolone 20 mg
twice daily, then tapered the dose every 4e5 days, and stopped it
Fig. 2. We followed and focused on the central three active punctate inner choroidopathy (PIC) lesions by spectrum-domain optical coherence tomography (SD-OCT). (A) Day 1. SD-
OCT showed dome-shaped retinal pigment epithelium (RPE) elevation with intact Bruch’s membrane, disappearance of photoreceptor inner/outer segment junction (PRJ), and
homogeneous sub-RPE hyperreﬂective signal. (B) Day 10. SD-OCT showed resolution of RPE change with visible overlying PRJ. The sub-RPE hyperreﬂective signals were still noted.
(C) Day 28. Above the hyperreﬂective signals, the localized outer plexiform layers (OPL) were gradually moving outward, and the corresponding RPE and PRJ were more depressed.
The hyperreﬂective signals were smaller and fainter. (D) Day 48. The RPE and PRJ were smoother, and the hyperreﬂective signals gradually became fainter.
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triamcinolone 40 mg were given on Day 15 to prevent further
choroidal neovascularization formation and decrease the inﬂam-
matory reaction.
On Day 10 (Fig. 2B), the SD-OCT showed regression of RPE
elevation, with overlying visible intact PRJ in a concave shape. The
homogenous sub-RPE hyperreﬂective signals were still noted. The
active lesions seemed to be smaller, with a clearer margin than the
initial color fundus pictures.
On Day 30 (Fig. 2C), the outer retinal layers overlying the active
lesions seemed to be moving outward at the level of outer nuclear
layer (ONL) and outer plexiform layer (OPL); the remaining sub-
RPE hyperreﬂective signals were still noted, but had shrunk in
diameter.
However, one active lesion temporal to the fovea seemed to
have PRJ disruption (Fig. 3), consistent with the hypoﬂuorescent
spot which had the hyperﬂuorescent crescent margin on the ICG
angiography (Fig. 1C).
The SD-OCT ﬁndings were unchanged after 1 month, and the
symptoms were also improved (Fig. 4). The administration of the
different kinds of medication ceased after 2 months, and no
symptomatic recurrence or change in SD-OCT was noted for the
next 3 months of follow-up. No ocular complications, such as
cataract formation or ocular hypertension, were noted during
follow-up. The ﬁnal visual acuity was 6/6 in both eyes.
3. Discussion
PIC was ﬁrst described by Watzke et al1 as small, multifocal,
yellow-white lesions originating from the choroid. However, theFig. 3. (A) Day 1. The bigger active punctate inner choroidopathy (PIC) lesions temporal-su
elevation with intact Bruch’s membrane (yellow arrow). (B) Day 30. More prominent ou
photoreceptor inner/outer segment junction (PRJ) discontinuity were noted, causing visualdeﬁnite pathophysiological origin of PIC has been debated for a
long time. In this study, our purpose was to utilize high resolution
SD-OCT to follow the structural changes in active PIC lesions before
and after treatment in a disease course of 5 months.
The initial ﬁndings of the three new central foci of PIC in high
resolution SD-OCT revealed dome-shaped RPE elevation, with the
overlying disappearance of the PRJ, intact BM, and underlying ho-
mogeneous hyperreﬂective signals below the lesions. No promi-
nent choroidal lesions were noted. After administration of oral
prednisolone, we observed the regression of RPE elevation and the
overlying visible intact PRJ in a concave shape, and similar sub-RPE
homogenous hyperreﬂective signals. After bevacizumab injection,
SD-OCT showed outward movement of the OPL and ONL in the
same three lesions. Our initial ﬁndings are compatible with the
clinical observation made by Watzke et al1 and Watzke and
Claussen10; serous RPE detachments occurred either at the ﬁrst
appearance of a new lesion or during recurrence. Therefore, we
hypothesize that the original localization of PIC may be related to
the outer retina, and more speciﬁcally, related to the RPE. The
inﬂammation in the RPE may cause RPE elevation as the initial
change before CNV formation.
Channa et al9 reported similar RPE and outer retinal changes in
the clinically active PIC lesions. Unfortunately, there were limita-
tions of image quality at the sub-RPE and choroid levelswith the use
of conventional Spectralis OCT. However, Cirrus OCTwith EDI mode
was capable of providing better image quality in the deep tissue. For
this reason, in this report, we are able to provide a better morpho-
logical view of active PIC lesions with the higher resolution SD-OCT.
In our study, the other, bigger active lesion, temporal-superior to
the fovea, seemed to have PRJ disruption (Fig. 3), which isperior to the fovea revealed the same dome-shaped retinal pigment epithelium (RPE)
ter plexiform layers (OPL) outward movement, sub-RPE hyperreﬂective signal, and
localized metamorphopsia.
Fig. 4. Visual ﬁeld showed central scotoma in the left eye on Day 7. After oral prednisolone and intravitreous bevacizumab injection, the symptoms improved and the central
scotoma disappeared on Day 32 and Day 60.
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ﬂuorescent crescent margin in the ICG angiography. Our inference
is that the serious inﬂammation has led to choroidal neo-
vascularization and outer retinal changes, including the disruption
in the PRJ and more prominent outward movement of the OPL. As
the disease progresses, it may lead to further disruption of the RPE
and choroid.
In previous studies we reviewed,11e14 bevacizumab was mainly
given when a CNV membrane developed in PIC disease. Pachydaki
et al15 made a clinicopathologic and ultrastructural report of CNV
membranes excised from the subretinal space. The study revealed
that well-formed neovascular units consistently exhibiting peri-
cytes may have been unresponsive to bevacizumab. Therefore, the
early intervention of bevacizumab before CNV membrane forma-
tion is likely to reduce the risk of CNV progression and prevent the
recurrence.
In conclusion, this report provides a morphological view of
active PIC lesions by high resolution SD-OCT. According to the serial
changes in SD-OCT, we hypothesize that the origin of PIC may be
localized at the RPE level. Furthermore, early detection and inter-
vention may prevent CNV formation and lead to a good prognosis.
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